(Q35123915)

6 August 2017

1 reference

title

Adherence to HAART regimens (English)

1 reference

6 August 2017

Adherence to HAART Regimens (English)

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

highly active antiretroviral therapy

31 December 2023

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12737640

31 December 2023

1

Margaret Chesney

1 reference

6 August 2017

Margaret Chesney

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12737640

31 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12737640

31 December 2023

publication date

1 April 2003

1 reference

full work available at URL

6 August 2017

http://www.liebertpub.com/doi/pdf/10.1089/108729103321619773

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

AIDS Patient Care and STDs

31 December 2023

published in

1 reference

6 August 2017

17

1 reference

6 August 2017

4

1 reference

6 August 2017

169-177

1 reference

Journal of Acquired Immune Deficiency Syndromes

6 August 2017

1

7

485

Lam NS

1994

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival

31 December 2023

2

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

31 December 2023

3

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

HIV-1 drug resistance in newly infected individuals

31 December 2023

4

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected Patients

31 December 2023

5

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4–8 viral load

31 December 2023

6

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials

31 December 2023

7

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome.

31 December 2023

8

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Discrepancies in the use of medications: their extent and predictors in an outpatient practice

31 December 2023

9

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease.

31 December 2023

10

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

The rational clinical examination. Is this patient taking the treatment as prescribed?

31 December 2023

11

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Inadequate Management of Blood Pressure in a Hypertensive Population

31 December 2023

12

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

The determinants of hypertension awareness, treatment, and control in an insured population

31 December 2023

13

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Measuring compliance with inhaled medication in asthma

31 December 2023

15

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique

31 December 2023

16

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Clinics in Chest Medicine

31 December 2023

17

10

375

Cuneo WD

1989

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Compliance with treatment regimens in chronic asymptomatic diseases

31 December 2023

20

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Congruence of three self-report measures of medication adherence among HIV patients

31 December 2023

21

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring

31 December 2023

22

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Metered-dose inhaler adherence in a clinical trial

31 December 2023

23

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Measuring medication adherence: are missed doses reported more accurately then perfect adherence?

31 December 2023

24

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications

31 December 2023

25

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Discordance between physician and adolescent assessments of adherence to treatment: influence of HbA1c level. The PEDIAB Collaborative Group

31 December 2023

26

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

How well do clinicians estimate patients' adherence to combination antiretroviral therapy?

31 December 2023

28

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Factors affecting adherence to antiretroviral therapy

31 December 2023

29

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

31 December 2023

30

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

31 December 2023

31

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Adherence to HIV combination therapy

31 December 2023

32

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

31 December 2023

33

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

31 December 2023

34

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

31 December 2023

35

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

31 December 2023

36

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

31 December 2023

37

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

31 December 2023

38

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

HIV protease inhibitor-related lipodystrophy syndrome

31 December 2023

40

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

31 December 2023

41

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

HIV protease inhibitors: advances in therapy and adverse reactions, including metabolic complications

31 December 2023

42

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease

31 December 2023

43

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Daily dosing of highly active antiretroviral therapy.

31 December 2023

46

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group

31 December 2023

47

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre.

31 December 2023

48

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease

31 December 2023

49

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.

31 December 2023

50

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Metabolic disorders among HIV-infected patients treated with protease inhibitors: a review

31 December 2023

51

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Estimating the population impact in Australia of improved antiretroviral treatment for HIV infection

31 December 2023

52

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

31 December 2023

53

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy

31 December 2023

54

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy.

31 December 2023

55

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

The relationship of disease severity, health beliefs and medication adherence among HIV patients

31 December 2023

56

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC

31 December 2023

57

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Long-term patient adherence to antiretroviral therapy

31 December 2023

58

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

31 December 2023

60

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Predictors of self-reported adherence in persons living with HIV disease

31 December 2023

61

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA.

31 December 2023

62

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Effects of food on clinical pharmacokinetics

31 December 2023

63

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Determinants of subject compliance within an experimental anti-HIV drug protocol

31 December 2023

64

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Racial differences in attitudes toward protease inhibitors among older HIV-infected men

31 December 2023

65

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors

31 December 2023

68

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patients

31 December 2023

69

1 reference

https://api.crossref.org/works/10.1089/108729103321619773

31 December 2023

Identifiers

1 reference

6 August 2017

1 reference